Latest literature | Zhongnan Medical Journal Press

Home Literature Latest literature

Latest literature

Efficacy of Dahuang Zhechong tablets in the treatment of patients with atrophic gastritis with intestinal metaplasia

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1546-1552.
2059 times 274 times

YE Hanting LIU Jiaxin ZHU Xiaoxiao LIU Dongbing FEI Kanqiang

Dahuang Zhechong tablets Weifuchun capsules Atrophic gastritis Intestinal metaplasia TCM syndromes Histopathology
Details
A retrospective study of natholimus mesylate on patients requiring continuous renal replacement therapy after cardiopulmonary resuscitation

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1537-1545.
2162 times 288 times

QIU Yimei ZHU Bin ZHAO Jing

Naprolimus mesylate Continuous renal replacement Oxidative stress Coagulation indicators Cerebral oxygen metabolism
Details
Clinical observation of vitamin D2 soft capsules in puerperae with severe preeclampsia

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1529-1536.
2080 times 289 times

CHENG Junjun HUANG Jiaqi

Severe preeclampsia Vitamin D2 soft capsules Coagulation function Oxidative stress Pregnancy outcome
Details
Analysis on efficacy of eszopiclone combined with duloxetine on sleep quality and quality of life in patients with depression and insomnia

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1523-1528.
1987 times 283 times

WANG Xiaoya WANG Jing XU Wenqiang

Duloxetine Eszopiclone Depression Insomnia Sleep quality
Details
Clinical observation on the efficacy of sacral-4 acupuncture therapy combined with tadalafil in the treatment of erectile dysfunction

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1516-1522.
2317 times 320 times

WANG Yongwei ZHAO Liangwei LI Shenghua

Erectile dysfunction Sacral-4 acupuncture Tadalafil Pudendal nerve electrical stimulation International index of erectile function Erection hardness score
Details
Influence of compound α-keto acid tablet combined with IMB intervention on quality of life in non-dialysis patients with stage G2-G3 CKD

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1509-1515.
2064 times 290 times

FANG Lingli XU Xiaoyan ZHOU Chunting YANG Zhihao

Chronic kidney disease Compound α-ketoacid tablet Information-motivation-behavior model Continuous intervention Quality of life
Details
Screening of 9 veterinary drug residues in Xiaohuoluo pills by LC-MS/MS

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1502-1508.
1833 times 284 times

LI Qing LUO Dingqiang HUANG Yan WU Fang NAN Ronghua WANG Mengqi

Xiaohuoluo pills Veterinary drug residues QuEChERS Liquid chromatography-tandem mass spectrometry
Details
Comparative study on UPLC characteristic chromatograms and multi-component content of Cirsium japonicum and Cirsium setosum medicinal materials

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1492-1501.
1851 times 297 times

FENG Yongwei ZHOU Lin LIU Xiaoxia DUAN Zhiwen CHEN Yuanyuan WEI Cuijie HE Minyou LI Zhenyu ZHANG Jun CHEN Xiangdong SUN Dongmei

Cirsium japonicum Cirsium setosum Ultra-performance liquid chromatography characteristic chromatograms Multi-component quantitative analysis
Details
Predictive analysis of quality markers of Poria cocos based on fingerprint and network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1482-1491.
2485 times 330 times

HUANG Guangwei HOU Li WU Xinhua

Poria cocos Fingerprint Chemical pattern recognition Network pharmacology Molecular docking Quality marker
Details
Chemical constituents of Capparis bodinieri Lévl.

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1469-1481.
1856 times 335 times

ZHAO Jianjun LI Qiqing LI Xiaohui

Capparis bodinieri Lévl. Chemical constituents Isolation and purification Structural identification
Details
Study on the mechanism of Runzao Zhiyang capsule in the treatment of atopic dermatitis based on UPLC-MS/MS and network pharmacology combined with molecular docking

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1460-1468.
2451 times 317 times

HOU Suyue LI Mengmeng WU Guijuan WANG Chun TANG Liu

Runzao Zhiyang capsule Atopic dermatitis Ultra performance liquid chromatography tandem mass spectrometry Network Pharmacology Mechanisms
Details
Potential role of Panax ginseng against triple-negative breast cancer based on network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1449-1459.
2069 times 323 times

CHEN Ziying SHI Yonghui LAI Songgui LYU Li ZHOU Yuehan

Panax ginseng Triple negative breast cancer Network pharmacology Molecular docking Molecular dynamics simulation
Details
Experimental observation and mechanism study on the effect of Rhodiola rosea tannin on cognitive impairment in mice with Alzheimer's disease

Published on Frontiers in Pharmaceutical Sciences 2025,29(9):1441-1448.
2098 times 326 times

CHEN Peng LI Ruixiang LI Changlin LEI Jiexin WANG Yu ZHOU Benhong

Rhodiola rosea tannin Alzheimer's disease Cognitive impairment Autophagy PI3K/Akt/mTOR pathway
Details
Ertugliflozin-induced euglycemic diabetic ketoacidosis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1108-1112.
1574 times 332 times

PAN Xuefen DAI Li SHAO Lingxia AI Jianguo

Ertugliflozin Euglycemic diabetic ketoacidosis Adverse drug reaction
Details
Clinical pharmacist participated in the drug treatment practice of a patient with ulcerative colitis accompanied by facial aseptic abscesses

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1094-1098.
1575 times 320 times

WU Liping ZHANG Peipei HU Naizhong WANG Yanyan

Ulcerative colitis Aseptic abscess Parenteral manifestation Infliximab Pharmaceutical care
Details
Expert consensus for off-label drug use of rare disease: a protocol

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1066-1073.
1668 times 349 times

CHEN Chaoyang DUAN Yuehan ZHUO Lin HE Guohua ZHANG Yanqin ZHOU Ying WANG Shengfeng CUI Yimin DING Jie

Rare disease Off-label use Expert consensus Study protocol
Details
Tirzepatide in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1057-1065.
5586 times 416 times

ZHANG Yunxuan ZHOU Haifeng GAO Ningzhou WU Jianbo QIAN Cheng ZHANG Min GUO Han SONG Zhongjuan LIU Xiaoyan

Tirzepatide Type 2 diabetes mellitus Rapid health technology assessment Efficacy Safety Cost-effectiveness
Details
KAP investigation and influential factor analysis on the risk of medication safety behavior among cancer patients in western Yunnan

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1049-1056.
1581 times 385 times

QUE Suyun MA Qiaoling ZHOU Xia CUN Yufang LI Bin XU Shidong MA Xi'na

Medication safety Behavioral risk Knowledge-attitude-behavior Oncology patients Factors affecting
Details
Study on the effects of sitagliptin and metformin combined with zoledronic acid on glycolipid metabolism and bone metabolism levels in patients with diabetes mellitus complicated with osteoporosis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1042-1048.
1699 times 360 times

CHEN Lu HUANG Ye GAO Peilin HUANG Lingli DING Rong

Type 2 diabetes mellitus Osteoporosis Sitagliptin and metformin Zoledronic acid Glucose and lipid metabolism Bone metabolism
Details
Risk factors of vancomycin-related acute kidney injury in elderly patients based on machine learning

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1032-1041.
1655 times 379 times

GUO Xinyu DAI Libo YANG Hongxin

Vancomycin Acute kidney injury Elderly patients Risk factor Machine learning
Details